44
In band
Moving averages
SMA 200$7.44+11.42%
Company profile
ImmunityBio, Inc., an immunotherapy company, develops a memory T-cell cancer vaccine to fight multiple types of tumors without the use of high-dose chemotherapy.
SectorHealthcare
IndustryBiotechnology
Market cap$10.73B
P/E ratioNone
EPS$-0.96
Beta0.03
Dividend yield0.00%
52-week high$12.43
52-week low$1.95
Similar stocks in Biotechnology
BNTX
BioNTech SE
RSI 41
VRTX
Vertex Pharmaceuticals Inc
RSI 68
CRSP
CRISPR Therapeutics AG
RSI 48
IOVA
Iovance Biotherapeutics Inc
RSI 30
BMRN
Biomarin Pharmaceutical Inc
RSI 55
TECH
Bio-Techne Corp
RSI 57
VKTX
Viking Therapeutics Inc
RSI 48
TARS
Tarsus Pharmaceuticals Inc
RSI 55
ATAI
ATAI Life Sciences N.V.
RSI 62
MRVI
Maravai LifeSciences Holdings Inc - Class A
RSI 54
RSI alerts for IBRX
An email when IBRX closes below RSI 30 or above 70. Nothing else.
Add alertData last updated 13 October 2026 at 9:03 PM EDT